COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 6,350.00
+26.00 (0.41%)
Oct 23, 2026, 3:30 PM JST
COSMOS Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Cash & Equivalents | 39,375 | 61,341 | 57,038 | 52,301 | 45,928 | 37,362 |
Cash & Short-Term Investments | 39,375 | 61,341 | 57,038 | 52,301 | 45,928 | 37,362 |
Cash Growth | -20.52% | 7.54% | 9.06% | 13.88% | 22.93% | -32.20% |
Accounts Receivable | 921 | 889 | 761 | 637 | 452 | 198 |
Other Receivables | - | 19,267 | 11,479 | 11,562 | 9,769 | 8,379 |
Receivables | 921 | 20,156 | 12,240 | 12,199 | 10,221 | 8,577 |
Inventory | 98,109 | 99,038 | 92,323 | 86,173 | 77,479 | 66,363 |
Prepaid Expenses | - | 3,087 | 2,857 | 2,568 | 2,429 | 2,189 |
Other Current Assets | 21,936 | 1,289 | 1,164 | 1,092 | 1,028 | 980 |
Total Current Assets | 160,341 | 184,911 | 165,622 | 154,333 | 137,085 | 115,471 |
Property, Plant & Equipment | 399,429 | 380,906 | 331,125 | 295,798 | 259,464 | 225,286 |
Long-Term Investments | - | 26,611 | 24,648 | 23,456 | 21,601 | 19,895 |
Other Intangible Assets | 1,040 | 933 | 446 | 497 | 547 | 433 |
Long-Term Deferred Tax Assets | - | 3,122 | 2,913 | 2,461 | 2,268 | 1,966 |
Other Long-Term Assets | 29,753 | 2 | 1 | 1 | 2 | 1 |
Total Assets | 590,563 | 596,485 | 524,755 | 476,546 | 420,967 | 363,052 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Accounts Payable | 188,974 | 195,796 | 177,125 | 179,549 | 161,852 | 139,224 |
Accrued Expenses | - | 10,496 | 9,812 | 8,057 | 7,272 | 6,234 |
Short-Term Debt | - | - | - | 4,581 | 2,741 | 1,387 |
Current Portion of Long-Term Debt | 8,784 | 8,784 | 5,682 | - | - | - |
Current Portion of Leases | - | 2,512 | 2,256 | 1,931 | 1,744 | 1,669 |
Current Income Taxes Payable | 4,604 | 20,629 | 23,550 | 17,420 | 16,787 | 12,234 |
Other Current Liabilities | 30,161 | 2,676 | 2,255 | 1,691 | 1,657 | 1,315 |
Total Current Liabilities | 232,523 | 240,893 | 220,680 | 213,229 | 192,053 | 162,063 |
Long-Term Debt | 59,693 | 61,889 | 37,202 | 23,385 | 10,018 | 3,000 |
Long-Term Leases | - | 5,291 | 4,817 | 4,166 | 3,698 | 3,357 |
Pension & Post-Retirement Benefits | 2,056 | 1,986 | 1,953 | 1,751 | 1,636 | 1,482 |
Other Long-Term Liabilities | 7,879 | 2,726 | 2,640 | 2,574 | 2,491 | 2,644 |
Total Liabilities | 302,151 | 312,785 | 267,292 | 245,105 | 209,896 | 172,546 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Common Stock | 4,178 | 4,178 | 4,178 | 4,178 | 4,178 | 4,178 |
Additional Paid-In Capital | 5,101 | 5,101 | 5,101 | 5,101 | 4,610 | 4,610 |
Retained Earnings | 279,136 | 274,411 | 248,309 | 222,284 | 202,485 | 181,954 |
Treasury Stock | -227 | -227 | -227 | -225 | -242 | -241 |
Comprehensive Income & Other | 224 | 237 | 102 | 103 | 40 | 5 |
Shareholders' Equity | 288,412 | 283,700 | 257,463 | 231,441 | 211,071 | 190,506 |
Total Liabilities & Equity | 590,563 | 596,485 | 524,755 | 476,546 | 420,967 | 363,052 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Total Debt | 68,477 | 78,476 | 49,957 | 34,063 | 18,201 | 9,413 |
Net Cash (Debt) | -29,102 | -17,135 | 7,081 | 18,238 | 27,727 | 27,949 |
Net Cash Growth | - | - | -61.17% | -34.22% | -0.79% | -37.42% |
Net Cash Per Share | -367.18 | -216.19 | 89.34 | 230.16 | 350.10 | 352.90 |
Filing Date Shares Outstanding | 79.26 | 79.26 | 79.26 | 79.26 | 79.2 | 79.2 |
Total Common Shares Outstanding | 79.26 | 79.26 | 79.26 | 79.26 | 79.2 | 79.2 |
Working Capital | -72,182 | -55,982 | -55,058 | -58,896 | -54,968 | -46,592 |
Book Value Per Share | 3638.94 | 3579.48 | 3248.45 | 2920.11 | 2665.11 | 2405.44 |
Tangible Book Value | 287,372 | 282,767 | 257,017 | 230,944 | 210,524 | 190,073 |
Tangible Book Value Per Share | 3625.81 | 3567.71 | 3242.82 | 2913.84 | 2658.21 | 2399.98 |